Benzinga | Nov 3, 2020 04:44AM EST

Piper Sandler Initiates Coverage On Kronos Bio with Overweight Rating, Announces Price Target of $50

Piper Sandler initiates coverage on Kronos Bio (NASDAQ:KRON) with a Overweight rating and announces Price Target of $50.